scholarly article | Q13442814 |
P356 | DOI | 10.1038/ONC.2010.481 |
P698 | PubMed publication ID | 21042279 |
P50 | author | Uğur Şahin | Q2505089 |
Özlem Türeci | Q92379963 | ||
P2093 | author name string | M Koslowski | |
U Luxemburger | |||
P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
A conserved family of prolyl-4-hydroxylases that modify HIF | Q24291794 | ||
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia | Q24315006 | ||
HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation | Q24555773 | ||
Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene | Q24595119 | ||
A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development | Q24681396 | ||
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation | Q27860876 | ||
The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 | Q28291340 | ||
Epigenetics in cancer | Q29547853 | ||
Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein | Q29615928 | ||
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics | Q29615944 | ||
Induction of Tumors in Mice by Genomic Hypomethylation | Q29618551 | ||
Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression | Q34579406 | ||
DNA methylation in cancer: too much, but also too little | Q34770545 | ||
Reactivating the expression of methylation silenced genes in human cancer | Q34770617 | ||
The subtle side to hypoxia inducible factor (HIFalpha) regulation | Q35072135 | ||
Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo | Q36369717 | ||
Hypoxia inducible factor-2alpha in cancer. | Q36778663 | ||
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein | Q37286026 | ||
Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2. | Q37431092 | ||
Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues | Q37679466 | ||
Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements | Q38339734 | ||
Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2. | Q39795314 | ||
Effects of DNA methylation on DNA-binding proteins and gene expression. | Q40912883 | ||
Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site | Q41027829 | ||
DNA methylation: a molecular lock | Q41441579 | ||
Positive autoregulation of the myogenic determination gene MyoD1. | Q44755585 | ||
Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development | Q45401730 | ||
Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues. | Q45948325 | ||
Frequent nonrandom activation of germ-line genes in human cancer. | Q52087806 | ||
The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes. | Q53614530 | ||
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype | Q57517773 | ||
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation | Q63253103 | ||
Hypomethylation of DNA from benign and malignant human colon neoplasms | Q69381419 | ||
EPAS1 trans-activation during hypoxia requires p42/p44 MAPK | Q73176153 | ||
NFATc1 autoregulation: a crucial step for cell-fate determination | Q80164088 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hypoxia | Q105688 |
P1104 | number of pages | 7 | |
P304 | page(s) | 876-882 | |
P577 | publication date | 2010-11-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α | |
P478 | volume | 30 |
Q89181309 | A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia |
Q34782024 | A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. |
Q64096270 | Assessment and site-specific manipulation of DNA (hydroxy-)methylation during mouse corticogenesis |
Q90398699 | Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system |
Q34429865 | Cooperativity of stress-responsive transcription factors in core hypoxia-inducible factor binding regions |
Q54287944 | Diet-induced hypoxia responsive element demethylation increases CEACAM6 expression, favouring Crohn's disease-associated Escherichia coli colonisation. |
Q93012064 | Differential placental DNA methylation of VEGFA and LEP in small-for-gestational age fetuses with an abnormal cerebroplacental ratio |
Q34747263 | Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia |
Q36836974 | Epigenetic regulation of CD34 and HIF1A expression during the differentiation of human mast cells |
Q39490284 | Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element. |
Q38084610 | Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics |
Q38096949 | Epigenetic regulation of hypoxia-responsive gene expression: focusing on chromatin and DNA modifications |
Q47651765 | Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity |
Q36573115 | Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis |
Q36395765 | Fetal stress-mediated hypomethylation increases the brain susceptibility to hypoxic-ischemic injury in neonatal rats |
Q90633236 | Gene-Specific Targeting of DNA Methylation in the Mammalian Genome |
Q39189766 | Genetics of the hypoxia-inducible factors in human cancers |
Q88540298 | Gestational Hypoxia and Developmental Plasticity |
Q34674453 | Gestational hypoxia and epigenetic programming of brain development disorders. |
Q38968823 | HIF-1 promotes the expression of its α-subunit via an epigenetically regulated transactivation loop. |
Q64099285 | HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia |
Q28505980 | HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth |
Q64086502 | Hypomethylation at non-CpG/CpG sites in the promoter of HIF-1α gene combined with enhanced H3K9Ac modification contribute to maintain higher HIF-1α expression in breast cancer |
Q26767183 | Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes |
Q37943792 | Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective |
Q37694101 | Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway. |
Q36294979 | Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells. |
Q40844302 | Probing the epigenetic regulation of HIF-1α transcription in developing tissue. |
Q37520359 | Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma |
Q48333559 | Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge. |
Q35557736 | Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection |
Q35892567 | TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma |
Q89575253 | TFF1 Promotes EMT-Like Changes through an Auto-Induction Mechanism |
Q36756817 | The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma. |
Search more.